CVRx® Appoints New Chief Marketing Officer and Vice President of European Sales and Marketing
January 05, 2021 10:55 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that it is expanding...
CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021
December 28, 2020 06:30 ET
|
CB Scientific, Inc.
ESCONDIDO, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...
Medical Digital Imaging Systems Market Size Worth USD 29.97 Billion By 2027 | Reports and Data
December 14, 2020 08:04 ET
|
Reports and Data
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The rising demand for disease diagnosis at an early stage is one of the significant factors influencing the medical digital imaging systems market growth....
CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status
December 03, 2020 11:54 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for...
CVRx® Announces New CFO and Acceleration of Barostim Therapy Commercialization Efforts
November 18, 2020 14:56 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- CVRx, Inc., developer of FDA-approved Barostim Therapy to treat chronic heart failure (HF), announced a CFO transition as part of the company’s...
CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
November 12, 2020 07:30 ET
|
CB Scientific, Inc.
ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
November 10, 2020 07:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and...
ASE Announces Its 2020-22 Leadership Academy Cohort
October 19, 2020 08:00 ET
|
American Society of Echocardiography
Durham, North Carolina, Oct. 19, 2020 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) is pleased to announce that 15 members have been chosen to make up the second cohort of the...
DEFINE PCI study one-year data show potential of treating residual ischemia to improve clinical outcomes for coronary stent patients
October 15, 2020 13:00 ET
|
Royal Philips
October 15, 2020 New data suggest that PCI guided by iFR co-registered on the angiogram can improve outcomes and reduce angina for patients more effectively than treatment guided by angiography...
CB Scientific, Inc. (CBSC) Announces the Launch of My-Cardia ECG Products and Services in Thailand
October 08, 2020 08:00 ET
|
CB Scientific, Inc.
ESCONDIDO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- via Network Wire -- CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...